Invitae Announces Favorable Reimbursement Coverage Decisions
With reimbursement coverage from Blue Shield of California and acceptance as a Medicare provider, Invitae looks to bring genetic testing into mainstream medicine.
Read MorePosted by Steve Halasey | Jan 6, 2015 | Cancer, Molecular Diagnostics, Pancreatic |
With reimbursement coverage from Blue Shield of California and acceptance as a Medicare provider, Invitae looks to bring genetic testing into mainstream medicine.
Read MorePosted by Jenny Lower | Dec 30, 2014 | Allergy & Autoimmune, Coagulation Testing, Hematology & Serology |
Akers Biosciences has entered into multiyear distribution agreements with Cryopep SARL and DiaLine AG for its PIFA Heparin and PF4 rapid assay products, which determine whether a patient being treated with the blood thinner heparin may be developing a drug allergy.
Read MorePosted by Steve Halasey | Dec 22, 2014 | Research |
In a study of 100 patients, test results from the Ativa point-of-care system are found to be comparable to results from larger, pricier central lab systems.
Read MorePosted by Jenny Lower | Dec 17, 2014 | Lab Automation |
While automation has long been regarded as an important means for clinical laboratories to achieve greater efficiency and accuracy, some laboratories have in the past been slow to adopt automation as a broad strategy.
Read MorePosted by Steve Halasey | Nov 11, 2014 | Hematology & Serology, Research |
Presentations at ACR are expected to offer new data about the diagnostic and clinical utility of blood tests for the protein 14-3-3 eta, considered a mechanistic biomarker for rheumatoid arthritis.
Read More